Related Experiment Video
Updated: Jul 19, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Asthma treatment costs using inhaled corticosteroids
S S Holzer1, L Engelhart, W H Crown
1American Academy of Otolaryngology-Head and Neck Surgery Foundation, Washington DC, USA.
The American Journal of Managed Care
|May 7, 1997
Summary
Triamcinolone acetonide (Azmacort) users incurred higher asthma healthcare costs than beclomethasone dipropionate (Vanceril/Beclovent) and flunisolide (Aerobid) users. These findings highlight economic differences in inhaled corticosteroid therapies for asthma management.
Area of Science:
- Pulmonary Medicine
- Health Economics
- Pharmacoeconomics
Background:
- Asthma is a prevalent chronic respiratory disease with significant economic burden in the US.
- Inhaled corticosteroids (ICS) are cornerstone therapies for asthma management.
- Understanding the economic impact of different ICS is crucial for healthcare resource allocation.
Purpose of the Study:
- To compare healthcare utilization expenditures among three inhaled corticosteroids: beclomethasone dipropionate, flunisolide, and triamcinolone acetonide.
- To identify potential economic benefits associated with specific ICS therapies in asthma patients.
Main Methods:
- Retrospective analysis of 4,441 patients' claims data from 1990-1993.
- Utilized inpatient, outpatient, and prescription drug claims from The MEDSTAT Group's MarketScan database.
- Employed multivariate linear regression to control for demographic and clinical factors.
Main Results:
- After excluding study drug costs, triamcinolone acetonide (Azmacort) users had higher total asthma healthcare expenditures than beclomethasone dipropionate (Vanceril/Beclovent) and flunisolide (Aerobid) users.
- Including study drug costs, both triamcinolone acetonide and flunisolide users showed higher expenditures compared to beclomethasone dipropionate users.
- No significant expenditure differences were found between beclomethasone dipropionate formulations (Vanceril and Beclovent).
Conclusions:
- Triamcinolone acetonide and flunisolide may be associated with higher overall asthma-related healthcare costs compared to beclomethasone dipropionate.
- Factors such as patient age, drug switching patterns, and comorbidities influence total asthma treatment expenditures.
- Further pharmacoeconomic research is warranted to optimize ICS selection for cost-effectiveness in asthma care.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...